MolNFT v1 · #33897 · protein
Crystal structure at 1.45- resolution of the major allergen endo-beta-1,3-glucanase of banana as a molecular basis for the latex-fruit syndrome
2CYG · Beta-1, 3-glucananse: “Crystal structure at 1.45- resolution of the major allergen endo-beta-1,3-glucanase of banana as a molecular…”. X-ray diffraction, 3 pockets (best druggability 0.43). MolNFT v1 #33897 on GenesisL1: 3D…
- PDB
- 2CYG
- Type
- protein
- Length
- 312 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-1, 3-glucananse
- EC
- 3.2.1.39
- UniProt
- O22317
- Pockets
- 3 · best druggability 0.43
Structure
x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-1, 3-glucananse (EC 3.2.1.39) | protein | 312 | 40% helix, 17% strand | O22317 |
Pockets
3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 104 | 0.43 | 0.78 | 16 | empty |
| 2 | 129 | 0.40 | 0.74 | 25 | empty |
| 3 | 103 | 0.38 | 0.75 | 23 | empty |
Compared structures
- 2CYG · Crystal structure at 1.45- resolution of the major allergen endo-beta-1,3-glucanase of… · the same entry in another collection · chain A against A, TM-score 1.00
- O22317 · AlphaFold monomer V2.0 prediction for glucan endo-1,3-beta- glucosidase (O22317) · a predicted model of the same protein · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O22317
- Elsewhere: RCSB PDB 2CYG · PDBe 2CYG · UniProt O22317
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.